Dendritic Cell Biology and Therapy

树突状细胞生物学和治疗

• 批准号: 8324798
• 负责人: Olivera J Finn
• 金额: $ 40.23万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-22 至 2016-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8324798
• 关键词: Address; Adjuvant; Animal Model; Antibodies; Antibody Formation; Antigen Targeting; Antigens; Autoimmunity; Biological Markers; Breast; CD4 Positive T Lymphocytes; Cancer Patient; Cancer Vaccines; Cell Therapy; Cells; Cellular biology; Clinical; Clinical Trials; Colon; Complex; Data; Dendritic Cells; Diagnosis; Disease; Drug Formulations; Frequencies; Future; Glycopeptides; Goals; Grant; Helper-Inducer T-Lymphocyte; Human; Immune; Immune response; Immune system; In Vitro; Instruction; Link; Lung; Macaca mulatta; Malignant neoplasm of pancreas; Memory; Methods; Modeling; Monkeys; Mucin-1 Staining Method; Mus; Pancreas; Particulate; Patients; Peptide Vaccines; Peptides; Phase; Phenotype; Population; Prevention; Primates; Process; Resected; Safety; Suggestion; T cell response; T-Lymphocyte; Tandem Repeat Sequences; Testing; Threonine; Transgenic Mice; Tumor Antigens; Vaccinated; Vaccines; base; cancer prevention; clinical efficacy; cytokine; efficacy trial; immune activation; in vivo; mouse model; neoplastic cell; next generation; patient population; pre-clinical; research study; response; tumor; vaccine candidate; vaccine efficacy